Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AZD9496

Catalog No. T3975Cas No. 1639042-08-2

AZD9496 is an orally available selective estrogen receptor(ERα) antagonist, with potential antineoplastic activity.

AZD9496

AZD9496

Purity: 98.47%
Catalog No. T3975Cas No. 1639042-08-2
AZD9496 is an orally available selective estrogen receptor(ERα) antagonist, with potential antineoplastic activity.
Pack SizePriceAvailabilityQuantity
1 mg$51In Stock
2 mg$71In Stock
5 mg$118In Stock
10 mg$198In Stock
25 mg$370In Stock
50 mg$548In Stock
100 mg$792In Stock
1 mL x 10 mM (in DMSO)$113In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "AZD9496"

Select Batch
Purity:98.47%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AZD9496 is an orally available selective estrogen receptor(ERα) antagonist, with potential antineoplastic activity.
Targets&IC50
ERα:0.28 nM.
In vitro
AZD9496 showed pmol/L equipotent binding to both ERα and ERβ isoforms. AZD9496 directly targets ERα for downregulation in vitro. And it also antagonizes and downregulates mutant ER in vitro and in vivo. The IC50s of ERα binding, ERα downregulation, ERα antagonism for AZD9496 are 0.82, 0.14 and 0.28 nM, respectively[1].
In vivo
AZD9496 showed high oral bioavailability across three species (F% 63, 91, and 74, rat, mouse, and dog, respectively) with generally low volume and clearance across species, albeit a higher clearance in mouse. The percent free levels in human plasma of 0.15% were 5-fold higher than those measured for fulvestrant. AZD9496 is a potent, oral inhibitor of breast tumor growth in vivo. AZD9496 causes tumor regressions in combination with PI3K pathway and CDK4/6 inhibitors and in an estrogen-deprived ER+ model of resistance. This effect was accompanied by a dose-dependent decrease in PR protein levels. AZD9496 is currently being evaluated in a phase I Clinicalal trial[1].
Cell Research
Cells were grown in steroid-free conditions in SILAC media containing 13C615N4 L-arginine to label ERα peptide as "heavy" and then switched to grow in media containing unlabeled l-arginine to label newly synthesized protein as "normal" with 0.1% DMSO, 300 nmol/L tamoxifen, 100 nmol/L AZD9496, or 100 nmol/L fulvestrant for the time indicated. (Only for Reference)
Chemical Properties
Molecular Weight442.47
FormulaC25H25F3N2O2
Cas No.1639042-08-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 82 mg/mL (185.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 82 mg/mL (185.3 mM)
Solution Preparation Table
DMSO/Ethanol
1mg5mg10mg50mg
1 mM2.2600 mL11.3002 mL22.6004 mL113.0020 mL
5 mM0.4520 mL2.2600 mL4.5201 mL22.6004 mL
10 mM0.2260 mL1.1300 mL2.2600 mL11.3002 mL
20 mM0.1130 mL0.5650 mL1.1300 mL5.6501 mL
50 mM0.0452 mL0.2260 mL0.4520 mL2.2600 mL
100 mM0.0226 mL0.1130 mL0.2260 mL1.1300 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AZD9496 | purchase AZD9496 | AZD9496 cost | order AZD9496 | AZD9496 chemical structure | AZD9496 in vivo | AZD9496 in vitro | AZD9496 formula | AZD9496 molecular weight